ROBERT W RUIZ

Allopathic & Osteopathic Physicians|Emergency Medicine EL CENTRO, CA NPI 1720147077

General Payments — all program years on this page

$456.59

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $442.05 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $442.0519

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABIOMED $108.284
Boehringer Ingelheim Pharmaceuticals, Inc. $70.273
GlaxoSmithKline, LLC. $49.992
Lilly USA, LLC $37.362
Exact Sciences Corporation $26.351
Amgen Inc. $26.251
ABBVIE INC. $24.941
Seqirus USA Inc $23.911
DEXCOM, INC. $21.561
PFIZER INC. $19.331
Acerta Pharma LLC $17.951
Novo Nordisk AS $15.861

By program year

Program yearAmountRecords
2021 $14.541
2024 $442.0519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105987985 ABBVIE INC. $24.94 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108566935 Novo Nordisk Inc $15.86 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116290282 GlaxoSmithKline, LLC. $26.11 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116325970 GlaxoSmithKline, LLC. $23.88 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117370667 Amgen Inc. $26.25 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118127245 Boehringer Ingelheim Pharmaceuticals, Inc. $20.88 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118127247 Boehringer Ingelheim Pharmaceuticals, Inc. $21.27 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118127249 Boehringer Ingelheim Pharmaceuticals, Inc. $28.12 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123310602 AstraZeneca Pharmaceuticals LP $17.95 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125635935 Seqirus USA Inc $23.91 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128385906 Exact Sciences Corporation $26.35 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131939103 PFIZER INC. $19.33 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135923420 Lilly USA, LLC $19.96 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135932340 Lilly USA, LLC $17.40 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142306568 ABIOMED $27.55 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142306570 ABIOMED $14.07 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142306572 ABIOMED $34.86 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142306674 ABIOMED $31.80 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153383900 Dexcom, Inc. $21.56 12/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.